GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Asset Turnover

Universal Ibogaine (TSXV:IBO) Asset Turnover : 0.11 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Universal Ibogaine's Revenue for the three months ended in Jan. 2024 was C$0.59 Mil. Universal Ibogaine's Total Assets for the quarter that ended in Jan. 2024 was C$5.56 Mil. Therefore, Universal Ibogaine's Asset Turnover for the quarter that ended in Jan. 2024 was 0.11.

Asset Turnover is linked to ROE % through Du Pont Formula. Universal Ibogaine's annualized ROE % for the quarter that ended in Jan. 2024 was -52.13%. It is also linked to ROA % through Du Pont Formula. Universal Ibogaine's annualized ROA % for the quarter that ended in Jan. 2024 was -15.96%.


Universal Ibogaine Asset Turnover Historical Data

The historical data trend for Universal Ibogaine's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Asset Turnover Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Asset Turnover
Get a 7-Day Free Trial - - - 0.25 0.17

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.07 0.10 0.12 0.11

Competitive Comparison of Universal Ibogaine's Asset Turnover

For the Biotechnology subindustry, Universal Ibogaine's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Asset Turnover falls into.



Universal Ibogaine Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Universal Ibogaine's Asset Turnover for the fiscal year that ended in Jul. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jul. 2023 )/( (Total Assets (A: Jul. 2022 )+Total Assets (A: Jul. 2023 ))/ count )
=1.03/( (6.318+5.502)/ 2 )
=1.03/5.91
=0.17

Universal Ibogaine's Asset Turnover for the quarter that ended in Jan. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jan. 2024 )/( (Total Assets (Q: Oct. 2023 )+Total Assets (Q: Jan. 2024 ))/ count )
=0.589/( (5.52+5.607)/ 2 )
=0.589/5.5635
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Universal Ibogaine  (TSXV:IBO) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Universal Ibogaine's annulized ROE % for the quarter that ended in Jan. 2024 is

ROE %**(Q: Jan. 2024 )
=Net Income/Total Stockholders Equity
=-0.888/1.7035
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.888 / 2.356)*(2.356 / 5.5635)*(5.5635/ 1.7035)
=Net Margin %*Asset Turnover*Equity Multiplier
=-37.69 %*0.4235*3.2659
=ROA %*Equity Multiplier
=-15.96 %*3.2659
=-52.13 %

Note: The Net Income data used here is four times the quarterly (Jan. 2024) net income data. The Revenue data used here is four times the quarterly (Jan. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Universal Ibogaine's annulized ROA % for the quarter that ended in Jan. 2024 is

ROA %(Q: Jan. 2024 )
=Net Income/Total Assets
=-0.888/5.5635
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.888 / 2.356)*(2.356 / 5.5635)
=Net Margin %*Asset Turnover
=-37.69 %*0.4235
=-15.96 %

Note: The Net Income data used here is four times the quarterly (Jan. 2024) net income data. The Revenue data used here is four times the quarterly (Jan. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Universal Ibogaine Asset Turnover Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines